Tabor Asset Management LP Makes New $1.88 Million Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Tabor Asset Management LP bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 168,400 shares of the pharmacy operator's stock, valued at approximately $1,881,000.

Several other large investors have also modified their holdings of the business. Proficio Capital Partners LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth about $312,000. Farther Finance Advisors LLC increased its holdings in Walgreens Boots Alliance by 31.4% during the 4th quarter. Farther Finance Advisors LLC now owns 7,661 shares of the pharmacy operator's stock worth $71,000 after purchasing an additional 1,830 shares during the period. Avantax Advisory Services Inc. increased its holdings in Walgreens Boots Alliance by 2.4% during the 4th quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock worth $466,000 after purchasing an additional 1,186 shares during the period. Corient Private Wealth LLC increased its holdings in Walgreens Boots Alliance by 4.0% during the 4th quarter. Corient Private Wealth LLC now owns 282,798 shares of the pharmacy operator's stock worth $2,639,000 after purchasing an additional 10,772 shares during the period. Finally, Signaturefd LLC increased its holdings in Walgreens Boots Alliance by 12.3% during the 4th quarter. Signaturefd LLC now owns 15,417 shares of the pharmacy operator's stock worth $144,000 after purchasing an additional 1,692 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Insider Buying and Selling

In related news, Chairman Stefano Pessina purchased 832,258 shares of the firm's stock in a transaction that occurred on Sunday, April 27th. The shares were acquired at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman owned 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock traded up $0.06 during midday trading on Thursday, reaching $11.59. The company had a trading volume of 3,617,926 shares, compared to its average volume of 16,578,355. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $10.03 billion, a price-to-earnings ratio of -1.59, a price-to-earnings-growth ratio of 1.35 and a beta of 0.78. The stock has a fifty day simple moving average of $11.37 and a 200 day simple moving average of $11.07. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm had revenue of $38.99 billion during the quarter, compared to analyst estimates of $36.72 billion. During the same quarter in the previous year, the business earned $0.63 EPS. The business's quarterly revenue was up 7.2% compared to the same quarter last year. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.